Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients: A Phase 4 "Real World" Experience Study From Kaiser Permanente Southern California
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Dec 2018
Price : $35 *
At a glance
- Drugs Ferric citrate (Primary)
- Indications Hyperphosphataemia
- Focus Pharmacodynamics
- 02 Aug 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 02 Aug 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 02 Aug 2018 Status changed from not yet recruiting to active, no longer recruiting.